Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Cardiovascular protection in females linked to estrogen-dependent inhibition of arterial stiffening and macrophage MMP12.

Liu SL, Bajpai A, Hawthorne EA, Bae Y, Castagnino P, Monslow J, Puré E, Spiller KL, Assoian RK.

JCI Insight. 2019 Jan 10;4(1). pii: 122742. doi: 10.1172/jci.insight.122742. [Epub ahead of print]

2.

Fatty acid profile and carcass traits of feedlot Nellore cattle fed crude glycerin and virginiamycin.

Castagnino PS, Fiorentini G, Dallantonia EE, San Vito E, Messana JD, Torrecilhas JA, Silva Sobrinho AG, Berchielli TT.

Meat Sci. 2018 Jun;140:51-58. doi: 10.1016/j.meatsci.2018.02.013. Epub 2018 Feb 27.

PMID:
29518741
3.

Stiffness-dependent motility and proliferation uncoupled by deletion of CD44.

Razinia Z, Castagnino P, Xu T, Vázquez-Salgado A, Puré E, Assoian RK.

Sci Rep. 2017 Nov 28;7(1):16499. doi: 10.1038/s41598-017-16486-z.

4.

Matrix metalloproteinase-12 is an essential mediator of acute and chronic arterial stiffening.

Liu SL, Bae YH, Yu C, Monslow J, Hawthorne EA, Castagnino P, Branchetti E, Ferrari G, Damrauer SM, Puré E, Assoian RK.

Sci Rep. 2015 Nov 26;5:17189. doi: 10.1038/srep17189.

5.

Effect of Lipid Sources with Different Fatty Acid Profiles on Intake, Nutrient Digestion and Ruminal Fermentation of Feedlot Nellore Steers.

Fiorentini G, Carvalho IP, Messana JD, Canesin RC, Castagnino PS, Lage JF, Arcuri PB, Berchielli TT.

Asian-Australas J Anim Sci. 2015 Nov;28(11):1583-91. doi: 10.5713/ajas.15.0130.

6.

Effect of lipid sources with different fatty acid profiles on the intake, performance, and methane emissions of feedlot Nellore steers.

Fiorentini G, Carvalho IP, Messana JD, Castagnino PS, Berndt A, Canesin RC, Frighetto RT, Berchielli TT.

J Anim Sci. 2014 Apr;92(4):1613-20. doi: 10.2527/jas.2013-6868. Epub 2014 Feb 3.

PMID:
24492580
7.

miR-221/222 compensates for Skp2-mediated p27 degradation and is a primary target of cell cycle regulation by prostacyclin and cAMP.

Castagnino P, Kothapalli D, Hawthorne EA, Liu SL, Xu T, Rao S, Yung Y, Assoian RK.

PLoS One. 2013;8(2):e56140. doi: 10.1371/journal.pone.0056140. Epub 2013 Feb 7.

8.

Apolipoprotein E-mediated cell cycle arrest linked to p27 and the Cox2-dependent repression of miR221/222.

Kothapalli D, Castagnino P, Rader DJ, Phillips MC, Lund-Katz S, Assoian RK.

Atherosclerosis. 2013 Mar;227(1):65-71. doi: 10.1016/j.atherosclerosis.2012.12.003. Epub 2012 Dec 19.

9.

Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening.

Kothapalli D, Liu SL, Bae YH, Monslow J, Xu T, Hawthorne EA, Byfield FJ, Castagnino P, Rao S, Rader DJ, Puré E, Phillips MC, Lund-Katz S, Janmey PA, Assoian RK.

Cell Rep. 2012 Nov 29;2(5):1259-71. doi: 10.1016/j.celrep.2012.09.018. Epub 2012 Oct 25.

10.

Studying the effects of matrix stiffness on cellular function using acrylamide-based hydrogels.

Cretu A, Castagnino P, Assoian R.

J Vis Exp. 2010 Aug 10;(42). pii: 2089. doi: 10.3791/2089.

11.

Cell-type- and cell-cycle-specific anti-mitogenesis by cicaprost.

Castagnino P, Kothapalli D, Hawthorne EA, Xu T, Assoian RK.

Prostaglandins Other Lipid Mediat. 2010 Sep;93(1-2):20-4. doi: 10.1016/j.prostaglandins.2010.04.004. Epub 2010 May 10.

12.

Cell-cycle control by physiological matrix elasticity and in vivo tissue stiffening.

Klein EA, Yin L, Kothapalli D, Castagnino P, Byfield FJ, Xu T, Levental I, Hawthorne E, Janmey PA, Assoian RK.

Curr Biol. 2009 Sep 29;19(18):1511-8. doi: 10.1016/j.cub.2009.07.069. Epub 2009 Sep 17.

13.

ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition.

Yin L, Castagnino P, Assoian RK.

Cancer Res. 2008 Feb 1;68(3):800-7. doi: 10.1158/0008-5472.CAN-07-2545.

14.

Rac-dependent cyclin D1 gene expression regulated by cadherin- and integrin-mediated adhesion.

Fournier AK, Campbell LE, Castagnino P, Liu WF, Chung BM, Weaver VM, Chen CS, Assoian RK.

J Cell Sci. 2008 Jan 15;121(Pt 2):226-33. doi: 10.1242/jcs.017012.

15.

Cell adhesion, cellular tension, and cell cycle control.

Klein EA, Yung Y, Castagnino P, Kothapalli D, Assoian RK.

Methods Enzymol. 2007;426:155-75. Review.

PMID:
17697884
16.

Post-transcriptional destabilization of p21cip1 by protein kinase C in fibroblasts.

Walker JL, Castagnino P, Chung BM, Kazanietz MG, Assoian RK.

J Biol Chem. 2006 Dec 15;281(50):38127-32. Epub 2006 Oct 16.

17.

Nuclear translocation of LIM kinase mediates Rho-Rho kinase regulation of cyclin D1 expression.

Roovers K, Klein EA, Castagnino P, Assoian RK.

Dev Cell. 2006 May;10(5):681. No abstract available.

18.

A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription.

Barlev NA, Emelyanov AV, Castagnino P, Zegerman P, Bannister AJ, Sepulveda MA, Robert F, Tora L, Kouzarides T, Birshtein BK, Berger SL.

Mol Cell Biol. 2003 Oct;23(19):6944-57.

19.
20.

Neu differentiation factor/heregulin induction by hepatocyte and keratinocyte growth factors.

Castagnino P, Lorenzi MV, Yeh J, Breckenridge D, Sakata H, Munz B, Werner S, Bottaro DP.

Oncogene. 2000 Feb 3;19(5):640-8.

21.

Human FRAG1 encodes a novel membrane-spanning protein that localizes to chromosome 11p15.5, a region of frequent loss of heterozygosity in cancer.

Lorenzi MV, Castagnino P, Aaronson DC, Lieb DC, Lee CC, Keck CL, Popescu NC, Miki T.

Genomics. 1999 Nov 15;62(1):59-66.

PMID:
10585768
22.

Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc42.

Lorenzi MV, Castagnino P, Chen Q, Hori Y, Miki T.

Oncogene. 1999 Aug 19;18(33):4742-55.

23.
24.

Induction of tissue inhibitor of metalloproteinases-3 is a delayed early cellular response to hepatocyte growth factor.

Castagnino P, Soriano JV, Montesano R, Bottaro DP.

Oncogene. 1998 Jul 30;17(4):481-92.

25.

Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases.

de Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, Roberts AB, Lechleider RJ.

Genes Dev. 1998 Jun 1;12(11):1587-92.

26.

Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations.

Lorenzi MV, Castagnino P, Chen Q, Chedid M, Miki T.

Oncogene. 1997 Aug 14;15(7):817-26.

27.

A protein-binding domain, EH, identified in the receptor tyrosine kinase substrate Eps15 and conserved in evolution.

Wong WT, Schumacher C, Salcini AE, Romano A, Castagnino P, Pelicci PG, Di Fiore PP.

Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9530-4.

28.

Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent.

Castagnino P, Biesova Z, Wong WT, Fazioli F, Gill GN, Di Fiore PP.

Oncogene. 1995 Feb 16;10(4):723-9.

PMID:
7532293
29.

Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals.

Fazioli F, Minichiello L, Matoska V, Castagnino P, Miki T, Wong WT, Di Fiore PP.

EMBO J. 1993 Oct;12(10):3799-808.

Supplemental Content

Loading ...
Support Center